EP300 and idiopathic pulmonary fibrosis: Interestingly, MIRLET7D-GOF in IPF fibroblasts did not significantly change the levels of total EP300, but reduced the levels of actEP300, suggesting inactivation of EP300 rather than its release from promoters.